Sierra oncology stock price
Oct 28, 2019 · SRRA, Sierra Oncology Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Sierra Oncology News - SRRA | ADVFN Sierra Oncology (SRRA) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. Sierra Oncology (NasdaqGM:SRRA) - Share price, News ... Executive Summary. Sierra Oncology, Inc., a clinical stage drug development company, is advancing targeted therapeutics for the treatment of patients with unmet medical needs in hematology and oncology. Sierra Oncology, Inc. (SRRA) stock price, quote, history ... Find the latest Sierra Oncology, Inc. (SRRA) stock quote, history, news and other vital information to help you with your stock trading and investing.
Stock analysis for Sierra Oncology Inc (SRRA:NASDAQ GM) including stock price , stock chart, company news, key statistics, fundamentals and company profile.
Stock Information. Sierra Oncology trades on the NASDAQ exchange under the symbol “SRRA”. The interactive chart below shows a historical timeline of our stock price and trading volume. Click on the tabs below to view the different timeframes. You may also view data on Dividend, Split, and Earning History by using the Events tab. SRRA - Sierra Oncology Inc Stock quote - CNNMoney.com Find real-time SRRA - Sierra Oncology Inc stock quotes, company profile, news and forecasts from CNN Business. Sierra Oncology Inc. Stock Price (SRRA) | Barron's View today's stock price, news and analysis for Sierra Oncology Inc. (SRRA). Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and more.
SRRA Stock Quote - Sierra Oncology, Inc. Common Stock ...
SRRA Stock Quote - Sierra Oncology, Inc. Common Stock ... Mar 30, 2020 · Stock quote for Sierra Oncology, Inc. Common Stock Common Stock (SRRA) with real-time last sale and extended hours stock prices, … SRRA - Stock quote for SIERRA ONCOLOGY, INC. - MSN Money View the latest SRRA stock quote and chart on MSN Money. Dive deeper with interactive charts and top stories of SIERRA ONCOLOGY, INC.. Sierra Oncology | Targeted Cancer Treatments | Contact Us
Sierra Oncology | Investor Relations - Stock Information
Sierra Oncology (SRRA) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more. Sierra Oncology (NasdaqGM:SRRA) - Share price, News ... Executive Summary. Sierra Oncology, Inc., a clinical stage drug development company, is advancing targeted therapeutics for the treatment of patients with unmet medical needs in hematology and oncology. Sierra Oncology, Inc. (SRRA) stock price, quote, history ... Find the latest Sierra Oncology, Inc. (SRRA) stock quote, history, news and other vital information to help you with your stock trading and investing.
SRRA | Sierra Oncology Inc. Stock Price & News - WSJ
SRRA Price Target and Analyst Ratings (Sierra Oncology) Nov 06, 2019 · 1 Wall Street analysts have issued ratings and price targets for Sierra Oncology in the last 12 months. Their average twelve-month price target is $1.20, suggesting that the stock has a possible downside of 86.65%. The high price target for SRRA is $1.20 and the low price target for SRRA is $1.20. Sierra Oncology Announces Reverse Stock Split - Jan 22, 2020 Jan 22, 2020 · The reverse stock split was approved by Sierra Oncology stockholders on January 21, 2020. Additional information regarding the reverse stock split, other matters voted upon, and the certified voting results will be filed on Form 8-K with the U.S. Securities and Exchange Commission. may only be exercised by paying the exercise price in cash
Sierra Oncology, Inc. (SRRA) Stock Price, Quote, History ... Sierra Oncology to Hold Year End 2019 & 2020 Outlook Analyst & Investor Call. VANCOUVER , Feb. 26, 2020 /CNW/ - Sierra Oncology, Inc. (SRRA), a late-stage drug development company focused on the registration and commercialization of momelotinib, a JAK1, JAK2 & ACVR1 inhibitor with a potentially differentiated therapeutic profile for the treatment of myelofibrosis, today … Sierra Oncology Inc., SRRA Quick Chart - (NAS) SRRA ... Sierra Oncology shares jump 7.3% premarket MarketWatch. Wednesday, February 22, 2017. 07:35 AM ET. Sierra Oncology upgraded to outperform from neutral at Wedbush Securities MarketWatch. 07:35 AM ET. Sierra Oncology stock price target raised to $4 from $3 at Wedbush Securities MarketWatch. Friday, June 10, 2016. 11:54 AM ET